Furthermore, retrospective studies showed that none of the patients with elevated levels of AFP mRNA included in the TCGA dataset can be identified as having hepatoid carcinomas due to the lack of HCC-like morphology [11–13], indicating that the HAS subtype is genetically distinct. This evidence concerns the gene AFP and hepatocellular carcinoma.